Globus Medical director gifts 2,500 shares

Globus Medical Inc. director David D. Davidar reported a bona fide gift of 2,500 shares of Class A Common Stock on July 27, 2026, at $0.00 per share.

Rhea-AI Filing Summary

Globus Medical Inc. director David D. Davidar reported a bona fide gift of 2,500 shares of Class A Common Stock on July 27, 2026, at $0.00 per share. After the gift, he directly holds 507,675 shares and has indirect ownership of 165,967 shares held in the Davidar Family Irrevocable Trust U/A 8/6/09 for the benefit of his spouse and children, with his spouse serving as trustee. The filing indicates this transaction was not made under a Rule 10b5-1 trading plan.

Insider Trade Summary

2,500 shares gifted

Gift 2 txns

Insider Davidar David D

Role Director

Type	Security	Shares	Price	Value
Gift	Class A Common Stock	2,500	$0.00	$0.00
holding	Class A Common Stock F1	--	--	--

Holdings After Transaction: Class A Common Stock — 507,675 shares (Direct); Class A Common Stock — 165,967 shares (Indirect, By Davidar Family Irrevocable Trust U/A 8/6/09)

Footnotes (1)

1. F1. These shares are held in a trust for the benefit of the reporting person's spouse and children. The reporting person's spouse is trustee of the trust.

Key Figures

Shares gifted: 2,500 shares Direct holdings after transaction: 507,675 shares Indirect holdings via trust: 165,967 shares

3 metrics

Shares gifted 2,500 shares Bona fide gift of Class A Common Stock on July 27, 2026

Direct holdings after transaction 507,675 shares Class A Common Stock held directly by David D. Davidar after the gift

Indirect holdings via trust 165,967 shares Class A Common Stock held indirectly through Davidar Family Irrevocable Trust U/A 8/6/09

Key Terms

Bona fide gift, Class A Common Stock, Irrevocable Trust, indirect ownership

4 terms

Bona fide gift financial

"Transaction coded G is described as a bona fide gift of shares"

A bona fide gift is a genuine, voluntary transfer of money, property, or benefits from one party to another made without expectation of repayment, services, or hidden conditions. Investors care because such gifts can affect company disclosures, related‑party transaction rules, tax treatment, and perceived conflicts of interest; think of it like someone giving you a present with no strings attached — but on a corporate scale, auditors and regulators need to verify it really is unconditional.

Class A Common Stock financial

"Security title reported as Class A Common Stock for the transaction"

Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.

Irrevocable Trust financial

"Shares held by the Davidar Family Irrevocable Trust U/A 8/6/09"

An irrevocable trust is a legal arrangement where an owner transfers assets into a separate entity managed by a trustee and gives up the power to modify or reclaim those assets. For investors it matters because putting stock or other holdings into such a trust can change who controls and benefits from the assets, affect taxes and creditor protection, and influence how easy it is to sell or value those holdings—like placing valuables in a locked safe overseen by someone else.

indirect ownership financial

"Ownership type noted as indirect through a family trust"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Globus Medical (GMED) report on July 27, 2026?

Globus Medical reported that director David D. Davidar made a bona fide gift of 2,500 shares of Class A Common Stock on July 27, 2026. The gift was recorded at $0.00 per share, reflecting a non-sale transfer with no proceeds received.

How many Globus Medical (GMED) shares does David D. Davidar hold after the reported gift?

After the gift, David D. Davidar directly holds 507,675 shares of Globus Medical Class A Common Stock. He also has 165,967 shares reported as indirectly owned through the Davidar Family Irrevocable Trust U/A 8/6/09.

Was the Globus Medical (GMED) stock gift made under a Rule 10b5-1 trading plan?

No. The Form 4 indicates the Rule 10b5-1 checkbox was not marked, meaning the 2,500-share gift was not executed under a Rule 10b5-1 trading plan. It is reported as a discretionary bona fide gift by the director.

Who benefits from the trust holding Globus Medical (GMED) shares for David D. Davidar?

The 165,967 Globus Medical shares reported as indirectly owned are held in a family irrevocable trust for the benefit of Davidar’s spouse and children. According to the footnote, his spouse serves as trustee of this trust.

What type of security was transferred in the Globus Medical (GMED) insider gift?

The transaction involved Class A Common Stock of Globus Medical. Director David D. Davidar transferred 2,500 shares as a bona fide gift on July 27, 2026, with the transaction price reported as $0.00 per share.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 07/28/2026 - 06:23 PM Accepted by SEC EDGAR 07/28/2026 - 06:22 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Davidar David D

(Last) (First) (Middle)

VALLEY FORGE BUSINESS CENTER

2560 GENERAL ARMISTEAD AVENUE

(Street)

AUDUBON PENNSYLVANIA 19403

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
GLOBUS MEDICAL INC [ GMED ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/27/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	07/27/2026		G		2,500	D	$0	507,675	D
Class A Common Stock								165,967	I	By Davidar Family Irrevocable Trust U/A 8/6/09(1)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These shares are held in a trust for the benefit of the reporting person's spouse and children. The reporting person's spouse is trustee of the trust.

	/s/ Kelly G. Huller, Attorney-in-Fact	07/28/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)